Aortic Valve Disease

IWBCA
Feb 15
10 min read

Aortic valve disease refers to structural and functional disorders of the aortic valve that impair forward blood flow from the heart or allow blood to leak backward, leading to symptoms ranging from exertional breathlessness to heart failure and requiring monitoring, medical optimization, and timely valve repair or replacement when disease becomes severe or symptomatic.

Overview

What is aortic valve disease?

Aortic valve disease involves problems with the valve that sits between the left ventricle and the aorta. The valve’s job is to open fully with each heartbeat to let blood exit the heart and to close tightly between beats to prevent backflow. When the valve does not open adequately, the heart must generate higher pressures to propel blood forward, and when the valve does not close adequately, blood leaks back into the left ventricle. Over time, these abnormal mechanics can remodel the heart muscle, reduce exercise capacity, trigger rhythm problems, and progress to heart failure. The clinical priority is to identify the specific valve problem, determine severity, monitor for progression, and intervene at the right time to prevent irreversible heart damage.

Normal Aortic Valve Function: The valve opens during systole to allow blood to leave the left ventricle and closes during diastole to maintain one-way flow.
Two Core Failure Patterns: Aortic stenosis limits forward flow by narrowing the valve opening, and aortic regurgitation allows backward flow by incomplete closure.
Why Timing Matters: Symptoms and certain imaging findings can signal that the heart is under strain, and delayed intervention can lead to persistent dysfunction even after the valve is treated.

Types

What are the main types of aortic valve disease?

Aortic valve disease is usually categorized by whether the valve is obstructed, leaky, infected, or structurally abnormal from birth. Many patients have mixed disease, such as stenosis with regurgitation, and the dominant lesion guides management. The underlying cause influences the speed of progression, associated heart and aortic findings, and the most appropriate treatment approach.

Aortic Stenosis: Aortic stenosis occurs when the valve opening becomes narrowed, creating a fixed obstruction to blood leaving the heart and increasing left ventricular pressure load.
Aortic Regurgitation: Aortic regurgitation occurs when the valve does not seal properly, causing blood to leak back into the left ventricle between beats and increasing volume load.
Aortic Valve Endocarditis: Endocarditis is an infection of the valve that can rapidly damage leaflets, create severe regurgitation, and generate systemic complications.
Subvalvular and/or Supravalvular Obstruction: Obstruction can occur below or above the valve in the aorta and may mimic stenosis, requiring distinct diagnostic approaches and treatment.
Mixed Aortic Valve Disease: Mixed disease includes both stenosis and regurgitation, and severity assessment focuses on which problem is driving symptoms and ventricular changes.
Bicuspid Aortic Valve: A bicuspid aortic valve is a congenital condition in which the valve has two leaflets instead of three and can lead to earlier stenosis, regurgitation, or aortic enlargement.

Symptoms

What are the most common symptoms associated with this condition?

Symptoms often develop gradually and may be mistaken for deconditioning, aging, asthma, or anxiety. Some people remain asymptomatic for years despite significant valve disease, which is why imaging surveillance can be essential. When symptoms appear, they often reflect the heart’s inability to increase output during activity or the development of congestion in the lungs and body. Symptoms that occur at rest, progress quickly, or appear alongside fainting or chest pressure require urgent assessment.

Exertional Shortness of Breath: Breathlessness during activity can occur when the heart struggles to increase forward flow or when pressures rise in the lungs.
Chest Pressure and/or Chest Pain: Chest discomfort can occur when the heart muscle’s oxygen demand rises due to pressure overload or when coronary flow becomes relatively insufficient during exertion.
Dizziness and/or Fainting: Lightheadedness or syncope may occur when cardiac output fails to increase adequately with exertion, particularly in cases of significant stenosis.
Fatigue and Reduced Exercise Tolerance: Fatigue can reflect reduced forward flow, inefficient cardiac mechanics, or early heart failure physiology.
Palpitations: Awareness of an irregular or rapid heartbeat may indicate atrial fibrillation, ectopy, or other rhythm disturbances that develop as the heart remodels.
Swelling and/or Rapid Weight Gain: Leg swelling, abdominal fullness, or rapid weight gain may indicate fluid retention associated with progressive heart failure.
Shortness of Breath at Rest and/or Waking at Night Gasping: Rest symptoms suggest advanced congestion and warrant prompt evaluation.

Causes

What causes aortic valve disease to develop?

Aortic valve disease can be caused by degenerative changes over time, congenital anatomy, inflammatory injury, infection, or dilation of the aortic root that pulls the valve leaflets apart. Identifying the cause is important because it influences the rate of progression, the likelihood of associated aortic disease, and treatment planning. Many patients have multiple contributing factors, such as congenital bicuspid aortic valve anatomy and age-related calcification.

Degenerative Calcification: Progressive calcium buildup can stiffen valve leaflets and narrow the opening, most often producing aortic stenosis that worsens over time.
Congenital Valve Anatomy: Bicuspid or otherwise abnormal valve structure can lead to earlier wear, stenosis, regurgitation, and associated enlargement of the ascending aorta.
Rheumatic Valve Disease: Prior inflammatory injury from rheumatic fever can scar the valve, leading to restricted motion and regurgitation or stenosis patterns that may coexist with mitral valve disease.
Aortic Root and/or Ascending Aorta Dilation: Enlargement of the aorta near the valve can prevent proper leaflet coaptation and produce regurgitation even if the leaflets themselves are relatively intact.
Infective Endocarditis: Infection can perforate or destroy leaflets, cause vegetations that impair closure, and produce acute severe regurgitation.
Trauma and/or Latrogenic Injury: Valve injury can occur after certain procedures, chest trauma, or radiation exposure, depending on the clinical context and timing.

Risk Factors

Who is at higher risk for developing aortic valve disease?

Risk depends on valve anatomy, age, and systemic conditions that promote calcification, inflammation, or vascular disease. Some risks are non-modifiable, such as a congenital bicuspid valve, while others can be addressed through long-term cardiovascular prevention. Risk recognition supports appropriate screening, earlier echocardiography, and timely referral when murmurs or symptoms appear.

Older Age: Degenerative calcific stenosis becomes increasingly common with advancing age.
Bicuspid Aortic Valve: Congenital bicuspid anatomy increases lifetime risk for stenosis, regurgitation, and enlargement of the ascending aorta.
Hypertension: Chronic elevated blood pressure contributes to left ventricular strain and can worsen the impact of regurgitation when the aorta dilates.
Chronic Kidney Disease: Kidney disease is associated with accelerated calcification, which can affect the valve.
Metabolic Risk Factors: Diabetes, dyslipidemia, and systemic vascular disease are associated with atherosclerotic and calcific pathways that may influence progression.
History of Rheumatic Fever: Prior rheumatic disease increases the likelihood of chronic valve scarring and dysfunction.
History of Endocarditis and/or High Endocarditis Risk: Prior infection, prosthetic valves, certain congenital heart conditions, and injection drug use increase endocarditis risk, which can damage the valve.

Diagnosis and Testing

How is aortic valve disease diagnosed and severity determined?

Diagnosis begins with history and physical exam, but echocardiography is the cornerstone because it directly evaluates valve structure, flow, and the heart’s response. Severity grading guides surveillance intervals and intervention timing. Testing also looks for associated diseases such as coronary artery disease, pulmonary hypertension, arrhythmias, and enlargement of the aorta, especially in bicuspid valve disease.

Physical Exam and Murmur Assessment: A murmur may suggest stenosis or regurgitation, and physical exam findings such as weak pulses, elevated jugular venous pressure, lung crackles, or edema can indicate advanced disease.
Transthoracic Echocardiogram: Echocardiography evaluates valve opening, leaflet motion, calcium burden, regurgitation severity, flow velocities, pressure gradients, left ventricular size and function, and pulmonary pressures.
Transesophageal Echocardiogram: Transesophageal echocardiography provides higher-resolution valve detail and is often used when transthoracic echocardiography is limited or when endocarditis is suspected.
Electrocardiogram: The ECG can reveal left ventricular hypertrophy, conduction disease, atrial fibrillation, or ischemic patterns that inform management decisions.
Chest Imaging: Chest X-ray and advanced imaging can assess heart size, lung congestion, and aortic enlargement when clinically indicated.
CT and/or MRI for Aorta and Valve Planning: Cross-sectional imaging can measure the aorta, clarify anatomy in bicuspid valve disease, and support procedural planning for transcatheter or surgical interventions.
Exercise Testing When Appropriate: Supervised testing can help identify symptoms in selected patients who report being asymptomatic and support safer decision-making regarding the timing of intervention.

Management and Treatment

How is aortic valve disease treated, and when is intervention needed?

Treatment depends on the type of valve disease, severity, symptoms, and the heart’s structural response. Medications can help manage blood pressure, fluid overload, and arrhythmias, but they do not reverse severe mechanical obstruction caused by stenosis. Valve intervention is considered when the disease is severe, when there is evidence of left ventricular failure or enlargement, or when certain high-risk features are present, even in the absence of symptoms. Treatment planning also accounts for age, frailty, anatomy, comorbidities, and patient goals.

Medical Management for Symptom Control: Diuretics, blood pressure medications, and rate- or rhythm-control medications can reduce congestion and improve function, particularly in regurgitation and heart failure.
Aortic Stenosis Intervention Thresholds: Severe stenosis with symptoms typically prompts valve replacement consideration, and certain imaging findings can support intervention in carefully selected asymptomatic patients.
Aortic Regurgitation Intervention Thresholds: Severe regurgitation is often treated with valve repair or replacement when symptoms develop, or when the left ventricle enlarges or exhibits reduced systolic function indicative of strain.
Surgical Aortic Valve Replacement: Surgical replacement is a definitive option across a wide range of anatomies and can be paired with repair of the aorta when dilation is present.
Transcatheter Aortic Valve Replacement: Transcatheter aortic valve replacement is a less invasive option for many patients with significant aortic stenosis, and candidacy depends on anatomy, vascular access, and overall risk profile.
Valve Repair and/or Root Surgery for Selected Regurgitation: Certain regurgitation causes can be addressed with repair or with aortic root procedures when dilation is the driver, depending on anatomy and surgical expertise.
Endocarditis Treatment Pathway: Endocarditis management includes targeted antibiotics and early surgical evaluation when complications arise, such as severe regurgitation, heart failure, abscess, or embolic risk.

Complications

What complications can occur if aortic valve disease progresses?

Complications reflect chronic pressure overload in stenosis, chronic volume overload in regurgitation, and the downstream effects of remodeling and congestion. Progression can be silent until advanced, and complications may emerge abruptly when the heart reaches a tipping point. Early identification and timely intervention reduce the chance that complications become permanent.

Heart Failure: Progressive valve dysfunction can lead to fluid overload, reduced exercise capacity, and eventual decompensation.
Arrhythmias: Atrial fibrillation and other rhythm disturbances can occur due to chamber enlargement and elevated filling pressures.
Syncope and/or Sudden Cardiac Events: Severe stenosis is associated with exertional syncope risk and can be associated with sudden deterioration, particularly when symptoms are present.
Pulmonary Hypertension: Chronic elevated pressures on the left side of the heart can transmit backward into the lungs and raise pulmonary artery pressures.
Stroke and/or Thromboembolism: Atrial fibrillation, endocarditis, and certain valve states can increase embolic risk.
Endocarditis: Abnormal valve structure and turbulent flow increase susceptibility to infection, particularly in high-risk clinical settings.
Aortic Aneurysm and/or Aortic Dissection Risk in Bicuspid Valve Disease: Associated aortic enlargement can progress and create separate risks that require parallel monitoring and treatment.

Living With Aortic Valve Disease

What does ongoing care look like after diagnosis?

Living with aortic valve disease typically involves periodic reassessment, symptom tracking, blood pressure management, and planning for escalation if the disease becomes severe. Many patients benefit from a clear surveillance schedule and explicit guidance on which symptoms should prompt earlier evaluation. Lifestyle guidance aims to support cardiovascular health without triggering unsafe physiologic stress, and care is often coordinated among primary care, cardiology, imaging teams, and valve specialists.

Surveillance Echocardiography Plan: Repeat echocardiograms are scheduled based on disease severity and progression risk to monitor valve function and ventricular response.
Blood Pressure Optimization: Consistent blood pressure control reduces ventricular strain and is particularly important in regurgitation and associated aortic dilation.
Symptom Monitoring and Activity Adjustment: Patients track exertional tolerance, breathlessness, chest pressure, and swelling patterns, and adjust activity based on symptom burden and clinician guidance.
Dental and Infection Prevention Planning: Patients at elevated risk of endocarditis may require individualized guidance on dental care and infection prevention strategies.
Pre-Procedure Planning and Valve Team Evaluation: Patients approaching intervention benefit from structured evaluation of procedural options, risks, durability considerations, and recovery planning.

Prevention

How can risk be reduced and progression slowed?

Not all aortic valve disease is preventable, particularly in cases of congenital and degenerative disease, but cardiovascular risk management supports overall cardiac health and can reduce the compounding strain. Prevention also includes early detection, since intervention timing is closely tied to outcomes. A focused prevention plan prioritizes blood pressure control, optimization of metabolic risk factors, and prompt evaluation of new symptoms or murmurs.

Cardiovascular Risk Factor Management: Lipid control, diabetes management, smoking cessation, and weight optimization support vascular health and reduce the burden of comorbid cardiac risk.
Hypertension Control: Stable blood pressure reduces left ventricular stress and may prevent symptom worsening in regurgitant states.
Early Evaluation of Murmurs and Symptoms: Prompt echocardiography when a new murmur or exertional symptoms appear supports earlier staging and safer long-term planning.
Endocarditis Risk Reduction: Patients at elevated risk benefit from individualized strategies to reduce exposure to infection and to recognize early warning signs of systemic infection.

Seeking Care

When should evaluation be urgent for possible aortic valve disease complications?

Some symptoms suggest progression to severe disease or acute decompensation and require rapid assessment. Urgency increases when symptoms are new, worsening, occur at rest, or appear alongside fainting or chest pressure. People with known valve disease should have a low threshold for evaluation when symptom patterns change, since progression can accelerate.

New or Worsening Chest Pressure and/or Chest Pain: Chest discomfort that is new, progressive, or associated with exertion should be evaluated promptly.
Fainting and/or Near-Fainting: Syncope can indicate severe stenosis or dangerous arrhythmias and warrants urgent assessment.
Shortness of Breath at Rest and/or Rapid Swelling: Rest dyspnea, sudden weight gain, and new edema can indicate decompensated heart failure.
Palpitations With Dizziness and/or Weakness: Palpitations with hemodynamic symptoms can reflect atrial fibrillation or other arrhythmias requiring prompt care.
Fever With Heart Symptoms and/or Unexplained Fatigue: Fever combined with new murmur changes, shortness of breath, or systemic symptoms raises concern for endocarditis in the appropriate clinical context.

Outlook

What is the long-term outlook for those with aortic valve disease?

Outlook depends on valve type, severity, cause, and the extent of heart adaptation at the time of treatment. Many patients with mild or moderate disease live well for years with surveillance and risk management. Severe stenosis and severe regurgitation carry meaningful risk when untreated, but modern surgical and transcatheter therapies often provide substantial symptom improvement and survival benefit when performed at the right time. Long-term care remains important after intervention because prosthetic valves require monitoring, and associated aortic disease, rhythm issues, or heart failure risk can persist.

Mild-to-Moderate Disease Course: Many patients remain stable for extended periods with regular echocardiographic monitoring and symptom tracking.
Severe Disease With Timely Intervention Outcomes are generally best when valve replacement or repair occurs before irreversible ventricular dysfunction develops.
Post-Intervention Monitoring Needs: Ongoing care includes periodic imaging, management of blood pressure and rhythm, and monitoring for prosthetic valve function and complications.
Bicuspid Valve and Aortic Surveillance: Patients with bicuspid anatomy often require long-term monitoring of the ascending aorta even after the valve itself is treated.

The IWBCA provides the information and materials on this site for educational and informational purposes only. The content is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider regarding any questions you may have about a medical condition, diagnosis, or course of treatment. Do not disregard, delay, or alter medical advice based on information obtained from this site. If you believe you are experiencing a medical emergency, call 911 or your local emergency services immediately.